by publisher – Page 25 – Retraction Watch

Publisher won’t retract most papers by chemist editor-in-chief who left university post under a cloud

The retractions appear to be trickling in for Thomas Webster, a once-prominent chemistry researcher who left his post at Northeastern University after nearly 70 of his papers were flagged on PubPeer for concerns about the data in the studies.

But while the publisher of a journal he co-founded — and left earlier this year — has retracted one paper, it said it would correct, not retract, nine of the papers he co-authored.

So far, we have seen two recent retractions for Webster, one involving a previously corrected 2015 paper in the journal Nanomedicine titled “Antibacterial and osteogenic stem cell differentiation properties of photoinduced TiO2 nanoparticle-decorated TiO2 nanotubes,” which has been cited 37 times, according to Clarivate Analytics’ Web of Science. The retraction notice for that article states:

Britney Spears story “remains as part of the publication record,” says Nature

A 2008 story in Nature about Britney Spears that prompted an apology from the author and the journal earlier this week “remains as part of the publication record,” Nature said in an editor’s note.

The story, titled “When Britney Spears comes to my lab,” appeared in a section of the journal called Nature Futures and refers to Spears “wearing a silver strapless stretch top that doesn’t show too much of her belly (unless she actually moves her arms), and black Capri pants with a little dip in the waistband.”

Spears, it said, would eventually go on to earn a PhD from Harvard and develop a treatment for diabetes. Before that, however, “Britney will pump out a lot of good data (she is something of a workaholic), but gradually, with her music, her intermittent marriages and pregnancies, not to mention her classes, the amount of time she spends in lab will begin to dwindle.”

In a note appended to the article sometime this week, following thousands of tweets and a Retraction Watch post, the editors write:

Journal retracts paper claiming two deaths from COVID-19 vaccination for every three prevented cases

Just days after adding an expression of concern to a paper published last week claiming that two people died from COVID-19 vaccinations for every three cases the vaccines prevented, the journal Vaccines has retracted the paper.

[See an update on this post, with more fallout from this case.]

As we have previously noted:

Paper claiming two deaths from COVID-19 vaccination for every three prevented cases earns expression of concern

A study published last week that quickly became another flashpoint for those arguing that COVID-19 vaccines are unsafe has earned an expression of concern.

[Please see an update on this post; the paper has been retracted.]

The original paper, published in the MDPI title Vaccines, claimed that:

The number of cases experiencing adverse reactions has been reported to be 700 per 100,000 vaccinations. Currently, we see 16 serious side effects per 100,000 vaccinations, and the number of fatal side effects is at 4.11/100,000 vaccinations. For three deaths prevented by vaccination we have to accept two inflicted by vaccination.

However, the study’s methods quickly drew scrutiny, and at least two members of Vaccines’ editorial board, Mount Sinai virologist Florian Krammer and Oxford immunologist Katie Ewer, said they have stepped down to protest the publication of the paper.

Britney Spears story prompts apology from Nature and author

Britney Spears has, as Retraction Watch readers no doubt know, been in the news a great deal lately, as the battle over her father’s “broad control over her life and finances” plays out in court. But a science fiction story about Spears that published in Nature in 2008 — the year Spears’ father was appointed her conservator — has prompted apologies from its author and the journal.

The story, which appeared in a section of the journal called Nature Futures, is titled “When Britney Spears comes to my lab.” It begins:

When Britney Spears comes to [Louisiana State University] LSU she’ll be wearing a silver strapless stretch top that doesn’t show too much of her belly (unless she actually moves her arms), and black Capri pants with a little dip in the waistband.

That and other passages in the piece — in which Spears goes on to earn a PhD from Harvard and discover a treatment for diabetes — caught the attention of more than 1,000 Twitter users since Friday. Many questioned why Nature would publish it. An example:

Paper by former NIH researcher alleging ‘Ponzi schemes’ by government, pharma retracted

Mahin Khatami, a former researcher with the U.S. National Institutes of Health who has argued in print that cancer results from ‘dark energy’ and that the government and the pharmaceutical industry are collaborating in ‘scientific/medical Ponzi schemes’ to keep people sick, has lost a paper to retraction.

As we reported last fall, Robert Speth, a pharmacy science researcher at Nova Southeastern University in Ft. Lauderdale, Fla., has been urging Clinical & Translational Medicine (CTM) to retract Khatami’s articles — and one in particular — for what is now more than two years.

In mid-October a spokesperson for Wiley, which publishes the journal, told us that she was trying to get more information from the editors about why Khatami’s bizarre paper was acceptable material.

Abstracts flagged because conferences — including one in Wuhan in late 2019 — may not have happened

A journal has issued an expression of concern after learning that it may have published abstracts from meetings that appear not to have taken place.

As many journals do, Basic & Clinical Pharmacology and Toxicology, a Wiley title, occasionally publishes meeting supplements. But according to the journal, it recently learned from several authors that a dozen of those supplements that it produced

between 2018 and 2020 might have contained suspect work. According to a statement we received from the journal:

The peer reviewers and editor wanted to publish my paper. The legal team rejected it.

Move over, Reviewer 2: The legal reviewer wants your job.

Last month, I was relieved when the journal Research Ethics published my article, “The Use of Confidentiality and Anonymity Protections as a Cover for Fraudulent Fieldwork Data.” One unexpected hurdle had almost thwarted publication. The problem wasn’t with the proverbial hard-to-please peer reviewer called Reviewer 2. Rather, the problem was with a behind-the-scenes reviewer of a different sort, Legal Reviewer 1.

I suspect that many authors have never heard of a legal reviewer. Yet depending on your research topics, you may have had your manuscripts delayed—or even rejected—without ever knowing of the powerful influence of persons in that role. In my case, the journal editor was candid in telling me that my manuscript would be sent to a “legal team” after clearing peer review.

Two meditation papers retracted for failures to report primary outcomes

A pair of psychology journals have retracted two related papers on the health benefits of a popular form of meditation after a reader pointed out that the authors failed to report the primary outcome of the study underpinning the articles.

The now-retracted articles describe the putatively salubrious effects of sahaj samadhi meditation, a form of meditation developed by Sri Sri Ravi Shankar and promoted by the Art of Living Foundation, which describes itself thusly:

Elsevier retracts entire book that plagiarized heavily from Wikipedia

The periodic table is, as a recent book notes, a guide to nature’s building blocks. But the building blocks of said book appear to have been passages from Wikipedia.

The book, The Periodic Table: Nature’s Building Blocks: An Introduction to the Naturally Occurring Elements, Their Origins and Their Uses, was published by Elsevier last year. But in December, Tom Rauchfuss, of the University of Illinois Urbana-Champaign, “tipped off by an Finnish editor on Wikipedia,” alerted the authors and Elsevier about the apparent plagiarism from the online encyclopedia.

On January 6, an Elsevier representative told Rauchfuss:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: